Literature DB >> 20089260

Toll-like receptor 4: a novel signaling pathway during renal fibrogenesis.

Matthew T Campbell1, Karen L Hile, Hongji Zhang, Hiroshi Asanuma, Brian A Vanderbrink, Richard R Rink, Kirstan K Meldrum.   

Abstract

BACKGROUND: The toll-like receptor (TLR) family serves an important regulatory role in the innate immune system, and recent evidence has implicated TLR signaling in the pro-inflammatory response of a variety of endogenous and exogenous stimuli within the kidney. The role of TLR signaling in fibrotic renal injury, however, remains unknown.
MATERIALS AND METHODS: C3H/HeJ TLR4 hyporesponsive mice (TLR4(Lps-d)) or WT controls (C3H/HeOu/J) underwent either sham operation or 1 wk of unilateral ureteral obstruction (UUO). The kidneys were harvested and tissues were analyzed for TLR4 expression (Western blot; RTPCR), E-cadherin and alpha smooth muscle actin (α-SMA) expression (Western blot), fibroblast accumulation (fibroblast specific protein (FSP-1+) staining), renal fibrosis (collagen I RTPCR, total collagen assay, Masson's trichrome staining), cytokine gene expression (tumor necrosis factor-alpha (TNF-α) and transforming growth factor-beta1 (TGF-β1) RTPCR), and pSMAD2 and integrin α1 expression (Western blot).
RESULTS: Mice with intact TLR4 signaling demonstrate a significant increase in TLR4 expression, α-SMA expression, fibroblast accumulation, collagen deposition, and interstitial fibrosis, and a significant decrease in E-cadherin expression in response to UUO. TLR4 deficient mice, however, exhibit a significant reduction in obstruction-induced α-SMA expression, fibroblast accumulation, and renal fibrosis, with preservation of E-cadherin expression. TLR4's influence on fibroblast accumulation and renal fibrosis occurred independent of any alterations in TNF-α, TGF-β1, or pSMAD2 expression, but did involve alterations integrin α1 expression.
CONCLUSION: TLR4 appears to be a significant mediator of fibrotic renal injury. While TLR4 signaling is recognized as a critical component of the innate immune response, this is the first study to demonstrate a novel role for TLR4 in renal fibroblast accumulation and tubulointerstitial fibrosis.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20089260      PMCID: PMC2888706          DOI: 10.1016/j.jss.2009.09.053

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  47 in total

Review 1.  Controlling TGF-beta signaling.

Authors:  J Massagué; Y G Chen
Journal:  Genes Dev       Date:  2000-03-15       Impact factor: 11.361

2.  TNF-alpha neutralization ameliorates obstruction-induced renal fibrosis and dysfunction.

Authors:  K K Meldrum; R Misseri; P Metcalfe; C A Dinarello; K L Hile; D R Meldrum
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-12-14       Impact factor: 3.619

3.  Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex.

Authors:  K Ohashi; V Burkart; S Flohé; H Kolb
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

Review 4.  Epithelial-mesenchymal transition and its implications for the development of renal tubulointerstitial fibrosis.

Authors:  Maria Pia Rastaldi
Journal:  J Nephrol       Date:  2006 Jul-Aug       Impact factor: 3.902

5.  Antibody to transforming growth factor-beta ameliorates tubular apoptosis in unilateral ureteral obstruction.

Authors:  A Miyajima; J Chen; C Lawrence; S Ledbetter; R A Soslow; J Stern; S Jha; J Pigato; M L Lemer; D P Poppas; E D Vaughan; D Felsen
Journal:  Kidney Int       Date:  2000-12       Impact factor: 10.612

6.  Integrin alpha1beta1 and transforming growth factor-beta1 play distinct roles in alport glomerular pathogenesis and serve as dual targets for metabolic therapy.

Authors:  D Cosgrove; K Rodgers; D Meehan; C Miller; K Bovard; A Gilroy; H Gardner; V Kotelianski; P Gotwals; A Amatucci; R Kalluri
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

7.  Effect of combination therapy with enalapril and the TGF-beta antagonist 1D11 in unilateral ureteral obstruction.

Authors:  Maher El Chaar; Jie Chen; Surya V Seshan; Sharda Jha; Ingride Richardson; Steven R Ledbetter; E D Vaughan; Dix P Poppas; Diane Felsen
Journal:  Am J Physiol Renal Physiol       Date:  2006-12-12

8.  The role of toll-like receptors 2 and 4 in acute allograft rejection after liver transplantation.

Authors:  J-F Deng; L Geng; Y-G Qian; H Li; Y Wang; H-Y Xie; X-W Feng; S-S Zheng
Journal:  Transplant Proc       Date:  2007-12       Impact factor: 1.066

9.  TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity.

Authors:  Binzhi Zhang; Ganesan Ramesh; Satoshi Uematsu; Shizuo Akira; W Brian Reeves
Journal:  J Am Soc Nephrol       Date:  2008-02-06       Impact factor: 10.121

Review 10.  Structure and function of Toll receptors and their ligands.

Authors:  Nicholas J Gay; Monique Gangloff
Journal:  Annu Rev Biochem       Date:  2007       Impact factor: 23.643

View more
  47 in total

1.  Toll-like receptor deficiency worsens inflammation and lymphedema after lymphatic injury.

Authors:  Jamie C Zampell; Sonia Elhadad; Tomer Avraham; Evan Weitman; Seth Aschen; Alan Yan; Babak J Mehrara
Journal:  Am J Physiol Cell Physiol       Date:  2011-11-02       Impact factor: 4.249

Review 2.  Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities.

Authors:  Swati Bhattacharyya; Jun Wei; John Varga
Journal:  Nat Rev Rheumatol       Date:  2011-10-25       Impact factor: 20.543

3.  Empagliflozin, SGLT2 inhibitor, attenuates renal fibrosis in rats exposed to unilateral ureteric obstruction: potential role of klotho expression.

Authors:  Noha A T Abbas; Amal El Salem; Mohammed M Awad
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-08-08       Impact factor: 3.000

4.  Profibrotic effect of interleukin-18 in HK-2 cells is dependent on stimulation of the Toll-like receptor 4 (TLR4) promoter and increased TLR4 expression.

Authors:  Kirstan K Meldrum; Hongji Zhang; Karen L Hile; Lyle L Moldower; Zizheng Dong; Daniel R Meldrum
Journal:  J Biol Chem       Date:  2012-10-01       Impact factor: 5.157

5.  HIF-1α promotes the keloid development through the activation of TGF-β/Smad and TLR4/MyD88/NF-κB pathways.

Authors:  Rui Lei; Jian Li; Feng Liu; Weihan Li; Shizhen Zhang; Yang Wang; Xi Chu; Jinghong Xu
Journal:  Cell Cycle       Date:  2019-10-23       Impact factor: 4.534

6.  Nuclear factor-kappa beta signaling is required for transforming growth factor Beta-2 induced ocular hypertension.

Authors:  Humberto Hernandez; Amanda L Roberts; Colleen M McDowell
Journal:  Exp Eye Res       Date:  2020-01-08       Impact factor: 3.467

Review 7.  Role of Toll-like receptor-4 in renal graft ischemia-reperfusion injury.

Authors:  Hailin Zhao; Jessica Santiváñez Perez; Kaizhi Lu; Andrew J T George; Daqing Ma
Journal:  Am J Physiol Renal Physiol       Date:  2014-02-12

8.  Requirement for TLR2 in the development of albuminuria, inflammation and fibrosis in experimental diabetic nephropathy.

Authors:  Jin Ma; Huiling Wu; Cathy Y Zhao; Usha Panchapakesan; Carol Pollock; Steven J Chadban
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

Review 9.  Regulation of wound healing and organ fibrosis by toll-like receptors.

Authors:  Peter Huebener; Robert F Schwabe
Journal:  Biochim Biophys Acta       Date:  2012-12-04

10.  Loganetin protects against rhabdomyolysis-induced acute kidney injury by modulating the toll-like receptor 4 signalling pathway.

Authors:  Jie Li; Yu-Jun Tan; Ming-Zhi Wang; Ying Sun; Guang-Yan Li; Qi-Long Wang; Jing-Chun Yao; Jiang Yue; Zhong Liu; Gui-Min Zhang; Yu-Shan Ren
Journal:  Br J Pharmacol       Date:  2019-03-27       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.